Discovering Clinical Study Experiences of Patients With Pulmonary Hypertension

Power Life Sciences Inc.500 enrolled

Overview

Taking part in medical trials usually favors a particular demographic group. But there is limited research available to explain what trial attributes affect the completion of these specific demographic groups. This study will admit a wide range of data on the clinical trial experience of pulmonary hypertension patients to determine which factors prevail in limiting a patient's ability to join or finish a trial. It will also try to analyze data from the perspective of different demographic groups to check for recurring trends which might yield insights for the sake of future pulmonary hypertension patients.

Study Type

OBSERVATIONAL

Enrollment

500

Conditions

Pulmonary Hypertension

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Aged ≥ 18 years old * Able to comprehend the investigational nature of the protocol and provide informed consent * Diagnosis of pulmonary hypertension Exclusion Criteria: * No diagnosis of pulmonary hypertension confirmed * Inability to perform regular electronic reporting * Patient does not understand, sign, and return consent form

Locations (1)

Power Life Sciences

San Francisco, California, United States

Outcomes

Primary Outcomes

Number of patients who decide to enroll in a pulmonary hypertension clinical research

Time frame: 3 months

Rate of patients who remain in pulmonary hypertension clinical research to trial completion

Time frame: 12 months